跳至主要内容
临床试验/NCT06010927
NCT06010927招募中4 期

Ketamine/Midazolam Premedication Versus Pre-extubation Ketofol. Effect on Emergence Agitation and Recovery Profile After Pediatric Adenotonsillectomy: A Randomized Comparative Study.

Cairo University2 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2023年8月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
140
试验地点
2
主要终点
incidence of Emergence agitation

研究概览

简要总结

An optimum recovery profile after AT includes a rapid, smooth awakening without emergence agitation (EA), stable vital signs and oxygenation, reduced postoperative nausea and vomiting (PONV), controlled postoperative pain, and patient or parents' satisfaction. Ketamine is a low-cost drug with a wide therapeutic window. Ketamine is a competitive N-methyl-D-aspartate receptor antagonist with good analgesic properties and periprocedural amnesia.

The ketamine/midazolam combination was administered in different ways with controversial results about their effect on the EA and recovery profile.

Ketofol, a mixture of ketamine and propofol, has been used in different favorable recovery profiles regarding postoperative EA and PONV.

This study aims to evaluate the effect of premedication with an intramuscular ketamine/ midazolam combination versus pre-extubation ketofol on the EA and the recovery profile.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Care Provider, Outcomes Assessor)

入排标准

年龄范围
3 Years 至 10 Years(Child)
性别
All
接受健康志愿者

入选标准

  • ASA physical status I or II
  • Children scheduled for AT under general anesthesia (GA).

排除标准

  • Congenital cardiovascular anomalies
  • Behavioral changes
  • Delayed physical development
  • Children receiving sedatives or anticonvulsants therapy

研究组 & 干预措施

Group-A; ketamine/midazolam premedication

Active Comparator

干预措施: ketamine/midazolam (Drug)

Group-B: Ketofol pre-extubation

Active Comparator

干预措施: Ketofol (Drug)

结局指标

主要结局

incidence of Emergence agitation

时间窗: starting from time of PACU admission after recover from anesthesia till 6 hours postoperative

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Abeer Ahmed, MD

Professor

Cairo University

研究点 (2)

Loading locations...

相似试验